FreeStyle Libre iCGM v2 offers greater accuracy and alarms – to adults & kids

image

Here’s what’s new in the second generation of the Libre flash glucose monitor

From Abbott’s press release
ABBOTT’S FREESTYLE® LIBRE 2 ICGM CLEARED IN U.S. FOR ADULTS AND CHILDREN WITH DIABETES, ACHIEVING HIGHEST LEVEL OF ACCURACY AND PERFORMANCE STANDARDS
– FreeStyle Libre 2 is the only integrated continuous glucose monitoring (iCGM) system available that continuously transmits glucose data every minute with customizable, optional real-time alarms to alert users when their glucose is high or low without scanning
– Now for children (ages 4 and older) and adults with diabetes, this latest technology is the first and only iCGM that sustains performance for up to 14 days, providing trends, insights and actionable data
– FreeStyle Libre 2 system includes a self-applied sensor (the size of two-stacked quarters) that is easiest glucose sensor to apply and worn on the back of the upper arm, eliminating the need for painful fingersticks to test glucose levels
– FreeStyle Libre portfolio has been extensively studied with the most real-world users, delivering proven health outcomes
– FreeStyle Libre 2 system offers enhanced features at the same affordable price as FreeStyle Libre 14 day system, which is a third of the cost of other CGMs
Full press release here

COVID-19 may cause worse outcomes in people with type 1 than type 2 diabetes

Screen Shot 2020-06-04 at 6.51.50 PM

I was first alerted to this in an article I saw in the British paper, The Guardian. I brought my concern to the group of global diabetologists I’m working with who are examining how COVID-19 is affecting people with diabetes.

Our British member, PhD Philip Home, responded to me immediately and walked me through the research. The reason type 1s may have worse outcomes if they get coronavirus than type 2s, in a nutshell, is vascular damage.

The story broke today on DiabetesDaily. Here’s the story.